Telehealth and discount medicines provider GoodRx has been ordered to pay a $1.5 million fine by the US authorities for sharing its customers' sensitive health information
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh